Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification (original) (raw)

• Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sorensen FB, Thykjaer T, Sauter G et al. (2006). SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res 66: 3434–3442.
  Article CAS PubMed Google Scholar
• Aslanian A, Iaquinta PJ, Verona R, Lees JA . (2004). Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev 18: 1413–1422.
  Article CAS PubMed PubMed Central Google Scholar
• Benedict WF, Lerner SP, Zhou J, Shen X, Tokunaga H, Czerniak B . (1999). Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer. Oncogene 18: 1197–1203.
  Article CAS PubMed Google Scholar
• Blais A, Dynlacht BD . (2004). Hitting their targets: an emerging picture of E2F and cell cycle control. Curr Opin Genet Dev 14: 527–532.
  Article CAS PubMed Google Scholar
• Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T et al. (2005). Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11: 7012–7022.
  Article CAS PubMed Google Scholar
• Bruch J, Schulz WA, Haussler J, Melzner I, Bruderlein S, Moller P et al. (2000). Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines. Cancer Res 60: 4526–4530.
  CAS PubMed Google Scholar
• Bruch J, Wohr G, Hautmann R, Mattfeldt T, Bruderlein S, Moller P et al. (1998). Chromosomal changes during progression of transitional cell carcinoma of the bladder and delineation of the amplified interval on chromosome arm 8q. Genes Chromosomes Cancer 23: 167–174.
  Article CAS PubMed Google Scholar
• Chapman EJ, Harnden P, Chambers P, Johnston C, Knowles MA . (2005). Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype. Clin Cancer Res 11: 5740–5747.
  Article CAS PubMed Google Scholar
• Chapman EJ, Hurst CD, Pitt E, Chambers P, Aveyard JS, Knowles MA . (2006). Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway. Oncogene 25: 5037–5045.
  Article CAS PubMed Google Scholar
• Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK et al. (2004). Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer. J Pathol 203: 762–770.
  Article CAS PubMed Google Scholar
• Christian BJ, Loretz LJ, Oberley TD, Reznikoff CA . (1987). Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. Cancer Res 47: 6066–6073.
  CAS PubMed Google Scholar
• Cooper CS, Nicholson AG, Foster C, Dodson A, Edwards S, Fletcher A et al. (2006). Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Lung Cancer 54: 155–162.
  Article PubMed Google Scholar
• Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z et al. (1992). Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst 84: 1251–1256.
  Article CAS PubMed Google Scholar
• Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC et al. (1998). Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 58: 1090–1094.
  CAS PubMed Google Scholar
• DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR . (1997). Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 94: 7245–7250.
  Article CAS PubMed PubMed Central Google Scholar
• Dimova DK, Dyson NJ . (2005). The E2F transcriptional network: old acquaintances with new faces. Oncogene 24: 2810–2826.
  Article CAS PubMed Google Scholar
• Dyson N . (1998). The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245–2262.
  Article CAS PubMed Google Scholar
• Evans AJ, Gallie BL, Jewett MA, Pond GR, Vandezande K, Underwood J et al. (2004). Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction. Am J Pathol 164: 285–293.
  Article CAS PubMed PubMed Central Google Scholar
• Feber A, Clark J, Goodwin G, Dodson AR, Smith PH, Fletcher A et al. (2004). Amplification and overexpression of E2F3 in human bladder cancer. Oncogene 23: 1627–1630.
  Article CAS PubMed Google Scholar
• Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Smith J et al. (2003). DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36: 361–374.
  Article CAS PubMed Google Scholar
• Frolov MV, Huen DS, Stevaux O, Dimova D, Balczarek-Strang K, Elsdon M et al. (2001). Functional antagonism between E2F family members. Genes Dev 15: 2146–2160.
  Article CAS PubMed PubMed Central Google Scholar
• He Y, Armanious MK, Thomas MJ, Cress WD . (2000). Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region. Oncogene 19: 3422–3433.
  Article CAS PubMed Google Scholar
• Humbert PO, Verona R, Trimarchi JM, Rogers C, Dandapani S, Lees JA . (2000). E2f3 is critical for normal cellular proliferation. Genes Dev 14: 690–703.
  CAS PubMed PubMed Central Google Scholar
• Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA . (2004). High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 23: 2250–2263.
  Article CAS PubMed Google Scholar
• Kallioniemi A, Kallioniemi O-P, Citro G, Sauter G, DeVries S, Kerschmann R et al. (1995). Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridisation. Genes Chromosomes Cancer 12: 213–219.
  Article CAS PubMed Google Scholar
• Lazzerini Denchi E, Attwooll C, Pasini D, Helin K . (2005). Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol Cell Biol 25: 2660.
  Article PubMed Google Scholar
• Le Frere-Belda MA, Gil Diez de Medina S, Daher A, Martin N, Albaud B, Heudes D et al. (2004). Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status. Hum Pathol 35: 817.
  Article CAS PubMed Google Scholar
• Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E et al. (1993). The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 13: 7813–7825.
  Article CAS PubMed PubMed Central Google Scholar
• Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS et al. (1998). E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev 12: 2120–2130.
  Article CAS PubMed PubMed Central Google Scholar
• Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L et al. (2000). Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol Cell Biol 20: 3626–3632.
  Article CAS PubMed PubMed Central Google Scholar
• Logothetis CJ, Xu H-J, Ro JY, Hu S-X, Sahin A, Ordonez N et al. (1992). Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 84: 1256–1261.
  Article CAS PubMed Google Scholar
• Oeggerli M, Schraml P, Ruiz C, Bloch M, Novotny H, Mirlacher M et al. (2006). E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer. Oncogene 25: 6538–6543.
  Article CAS PubMed Google Scholar
• Oeggerli M, Tomovska S, Schraml P, Calvano-Forte D, Schafroth S, Simon R et al. (2004). E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene 23: 5616–5623.
  Article CAS PubMed Google Scholar
• Olsson AY, Feber A, Edwards S, Te Poele R, Giddings I, Merson S et al. (2007). Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene 26: 1028–1037.
  Article CAS PubMed Google Scholar
• Orlic M, Spencer CE, Wang L, Gallie BL . (2006). Expression analysis of 6p22 genomic gain in retinoblastoma. Genes Chromosomes Cancer 45: 72–82.
  Article CAS PubMed Google Scholar
• Paulie S, Hansson Y, Lundblad ML, Perimann P . (1983). Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines. Int J Cancer 31: 297–303.
  Article CAS PubMed Google Scholar
• Paulson QX, McArthur MJ, Johnson DG . (2006). E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model. Cell Cycle 5: 184–190.
  Article CAS PubMed Google Scholar
• Prat E, Bernues M, Caballin MR, Egozcue J, Gelabert A, Miro R . (2001). Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization. Urology 57: 986–992.
  Article CAS PubMed Google Scholar
• Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H et al. (2007). Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331–1336.
  Article CAS PubMed Google Scholar
• Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL et al. (2007). A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341–1345.
  Article CAS PubMed PubMed Central Google Scholar
• Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB et al. (2007). A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39: 770–775.
  Article CAS PubMed Google Scholar
• Stevens C, La Thangue NB . (2004). The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair (Amst) 3: 1071–1079.
  Article CAS Google Scholar
• Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S et al. (1998). The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17: 5001–5014.
  Article CAS PubMed PubMed Central Google Scholar
• Tomlinson DC, Hurst CD, Knowles MA . (2007). Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer. Oncogene 26: 5889–5899.
  Article CAS PubMed PubMed Central Google Scholar
• Tomovska S, Richter J, Suess K, Wagner U, Rozenblum E, Gasser TC et al. (2001). Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer. Int J Oncol 18: 1239–1244.
  CAS PubMed Google Scholar
• Trimarchi JM, Lees JA . (2002). Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3: 11–20.
  Article CAS PubMed Google Scholar
• Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S et al. (2003). Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63: 2872–2880.
  CAS PubMed Google Scholar
• Wu Q, Hoffmann MJ, Hartmann FH, Schulz WA . (2005). Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer. Mol Cancer 4: 16.
  Article PubMed PubMed Central Google Scholar
• Xu HJ, Cairns P, Hu SX, Knowles MA, Benedict WF . (1993). Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int J Cancer 53: 781–784.
  Article CAS PubMed Google Scholar
• Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O, Reznikoff C . (1995). Increased p16 levels correlate with pRB alterations in human urothelial cells. Cancer Res 55: 493–497.
  CAS PubMed Google Scholar
• Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H et al. (2007). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316: 1336–1341.
  Article CAS PubMed PubMed Central Google Scholar
• Ziebold U, Lee EY, Bronson RT, Lees JA . (2003). E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas. Mol Cell Biol 23: 6542–6552.
  Article CAS PubMed PubMed Central Google Scholar
• Ziebold U, Reza T, Caron A, Lees JA . (2001). E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev 15: 386–391.
  Article CAS PubMed PubMed Central Google Scholar